Gilat Efroni

460 total citations
14 papers, 297 citations indexed

About

Gilat Efroni is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Gilat Efroni has authored 14 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Gilat Efroni's work include Gut microbiota and health (6 papers), Inflammatory Bowel Disease (3 papers) and Microscopic Colitis (2 papers). Gilat Efroni is often cited by papers focused on Gut microbiota and health (6 papers), Inflammatory Bowel Disease (3 papers) and Microscopic Colitis (2 papers). Gilat Efroni collaborates with scholars based in Israel and United States. Gilat Efroni's co-authors include Iris Lavon, Tali Siegal, Yakov Fellig, Dana Fuchs, Bracha Zelikovitch, Yael Haberman, Tzipi Braun, Amnon Amir, Efrat G. Saar and Batia Weiss and has published in prestigious journals such as Nature Communications, Gastroenterology and Cancer Research.

In The Last Decade

Gilat Efroni

14 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilat Efroni Israel 8 170 59 52 46 37 14 297
Mingfa Ling China 10 234 1.4× 27 0.5× 78 1.5× 38 0.8× 28 0.8× 11 383
Xiuli Lin China 11 196 1.2× 51 0.9× 18 0.3× 18 0.4× 58 1.6× 21 361
Zhen-Yang Gu China 9 206 1.2× 16 0.3× 57 1.1× 56 1.2× 32 0.9× 29 364
Giulia Pontarollo Germany 12 216 1.3× 13 0.2× 17 0.3× 24 0.5× 28 0.8× 20 369
Huimin Jin China 11 137 0.8× 14 0.2× 52 1.0× 79 1.7× 30 0.8× 29 323
Harish P. Janardhan United States 11 263 1.5× 13 0.2× 27 0.5× 72 1.6× 50 1.4× 16 401
Di Cao China 12 185 1.1× 53 0.9× 79 1.5× 15 0.3× 47 1.3× 31 413
Zhaofu Li China 8 190 1.1× 8 0.1× 60 1.2× 21 0.5× 42 1.1× 19 352
Luz María Torres‐Espíndola Mexico 9 120 0.7× 18 0.3× 41 0.8× 69 1.5× 24 0.6× 34 323

Countries citing papers authored by Gilat Efroni

Since Specialization
Citations

This map shows the geographic impact of Gilat Efroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilat Efroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilat Efroni more than expected).

Fields of papers citing papers by Gilat Efroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilat Efroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilat Efroni. The network helps show where Gilat Efroni may publish in the future.

Co-authorship network of co-authors of Gilat Efroni

This figure shows the co-authorship network connecting the top 25 collaborators of Gilat Efroni. A scholar is included among the top collaborators of Gilat Efroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilat Efroni. Gilat Efroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sher, Ifat, G Altmann, A Sabó, et al.. (2024). Housing RCS rats under specific pathogen-free conditions mildly ameliorates retinal degeneration and alters intestine microbiota. Scientific Reports. 14(1). 21583–21583. 1 indexed citations
2.
Hadar, Rotem, Joseph N. Paulson, Gilat Efroni, et al.. (2024). Lubricating gel influence on vaginal microbiome sampling. Scientific Reports. 14(1). 18223–18223. 1 indexed citations
3.
Hadar, Rotem, Tzipi Braun, Gilat Efroni, et al.. (2024). Lack of gut microbiome recovery with spinal cord injury rehabilitation. Gut Microbes. 16(1). 2309682–2309682. 5 indexed citations
4.
Rathaus, M., Idit Ron, Rotem Hadar, et al.. (2024). Long-term metabolic effects of non-nutritive sweeteners. Molecular Metabolism. 88. 101985–101985. 12 indexed citations
5.
Haberman, Yael, Iris Kamer, Amnon Amir, et al.. (2023). Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit. Scientific Reports. 13(1). 2007–2007. 12 indexed citations
6.
Braun, Tzipi, Gilat Efroni, Orit Picard, et al.. (2023). Baseline Peripheral Blood Mononuclear Cell Transcriptomics Before Ustekinumab Treatment Is Linked With Crohn's Disease Clinical Response at 1 Year. Clinical and Translational Gastroenterology. 14(12). e00635–e00635. 1 indexed citations
7.
Segal, Eran, et al.. (2022). Outbreak of Sepsis Following Surgery: Utilizing 16S RNA Sequencing To Detect the Source of Infection. Cureus. 14(2). e22487–e22487. 5 indexed citations
8.
Amir, Amnon, Tzipi Braun, Rotem Hadar, et al.. (2022). Gut microbiome development in early childhood is affected by day care attendance. npj Biofilms and Microbiomes. 8(1). 2–2. 27 indexed citations
10.
Segni, Ayelet Di, Gilat Efroni, Tzipi Braun, et al.. (2019). Defining the Celiac Disease Transcriptome using Clinical Pathology Specimens Reveals Biologic Pathways and Supports Diagnosis. Scientific Reports. 9(1). 16163–16163. 28 indexed citations
11.
Braun, Tzipi, Ayelet Di Segni, Sandra Neuman, et al.. (2019). Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares. The American Journal of Gastroenterology. 114(7). 1142–1151. 53 indexed citations
12.
Efroni, Gilat, et al.. (2016). De-novo protein function prediction using DNA binding and RNA binding proteins as a test case. Nature Communications. 7(1). 13424–13424. 18 indexed citations
13.
Lavon, Iris, Dana Fuchs, Gilat Efroni, et al.. (2007). Novel Mechanism whereby Nuclear Factor κB Mediates DNA Damage Repair through Regulation of O6-Methylguanine-DNA-Methyltransferase. Cancer Research. 67(18). 8952–8959. 107 indexed citations
14.
Lavon, Iris, et al.. (2003). A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation. Molecular Pharmacology. 64(6). 1334–1341. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026